ULS cDNA Synthesis and Labeling Kit (with Cy3 and Cy5) from KREATECH Biotechnology
Description:The ULS cDNA Synthesis and Labeling Kit generates labeled cDNA for use in microarray hybridization experiments. First unmodified cDNA is made via a reverse transcription from mRNA into cDNA using an Oligo(dT) primer. Unlike other methods, there are no unnatural modified nucleotides used in the reverse transcription reaction. This unmodified cDNA is then labeled in a one step 30 min. reaction with...ULS cDNA Synthesis and Labeling Kit (with Biotin) from KREATECH Biotechnology
Description:The ULS cDNA Synthesis and Labeling Kit generates labeled cDNA for use in microarray hybridization experiments. First unmodified cDNA is made via a reverse transcription from mRNA into cDNA using an Oligo(dT) primer. Unlike other methods, there are no unnatural modified nucleotides used in the reverse transcription reaction. This unmodified cDNA is then labeled in a one step 30 min. reaction with...PlateCrane EX from Hudson Control Group, Inc.
Description:...Stratatech Receives another NIH Grant
, a UW spin-off company, has received a $168,000 Phase I SBIR Grant from the National Institute on Aging, for the development of cell-based gene therapy products for the treatment of chronic skin wounds such as diabetic, venous stasis and pressure ulcers, which are particularly problematic for the aged popul...Stratatech Receives $4 Million Federal Grant
Under this grant, Stratatech will work to develop a genetically engineered therapeutic human skin substitute with enhanced antimic...Stratatech receives nearly $1 million
Established in 2000, Stratatech is based in Madison and employs 18 people, according to the 2005 edition of the Gre...Stratatech and Virent Win $4M in U.S. Grants
MADISON, WI - U.S. Representative Tammy Baldwin and Wisconsin Governor James Doyle have announced that two Wisconsin companies will each receive federal grants of $2 million to further their cutting-edge research and product development efforts. Both based in Madison, is developing "StrataGraft" skin tiss...Catechins in green tea show antiviral effect on influenza virus
Green tea is produced from the leaves of the evergreen plant Camellia sinensis . The major active ingredients of green tea are polyphenolic compounds, known as catechins. Catechins of green tea leaves account for about 10% of dry // ht, including (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG) and (-)-epicatechin (EC), where EGCG accounts fo...First-Ever Robotic Pancreatectomy Performed at UIC
Surgeons at the University of Illinois Medical Center at Chicago performed a groundbreaking robotic pancreatectomy in a 39-year-old man to relieve him of debilitating pain. They also performed an autologous islet cell transplant to prevent him from developing surgical diabetes. Terry Near, of Rock Falls, Ill., is the first patient in the world to undergo a pancreatectomy, or remova...Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy
Those men who are facing the surgical removal of the prostate due to cancer may hope that a day will come when they need not worry about the post-surgical urinary incontinence. That's because a team of expert urologic surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has devised a simple, effective means of reconstructing key anatomical structures that ensure c...Quick, Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy
Thousands of men facing surgical removal of the prostate due to cancer may someday have one less thing to worry about: post-surgical urinary incontinence. That's because a team of expert urologic surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has devised a simple, effective means of reconstructing key anatomical structures that ensure continence....Theratechnologies: TH9507 Phase 3 Clinical Update
- Data from first Phase 3 trial presented at ENDO 2007 - Regulatory approvals for second Phase 3 trial open the door forpatient recruitment in Europe MONTREAL, QUEBEC -- (MARKET WIRE) -- June 04, 2007 --Theratechnologies (TSX: TH) reported today that 26-week data fromits first Phase 3 study testing TH9507 in HIV-associatedlipodystrophy were presented today in Toronto...Quest PharmaTech's Prostate Cancer Program Update
Trading Symbol: QPT: TSX Venture Exchange EDMONTON, May 02, 2007 /PRNewswire-FirstCall/ - Quest PharmaTechInc. ("Quest" or the "Company") Quest is pleased to provide anupdate on the pre-clinical development of SL052 for the treatmentof prostate cancer. Prostate cancer is the second leading cause of cancer death inAmerican men with approximately 230,000 new cases and 30,000 deathspe...